UB Paderborn / Katalog / Suche / in CDI

Are women benefiting from the Affordable Care Act? A real-world evaluation of the impact of the Affordable Care Act on out-of-pocket costs for contraceptives

Contraception (Stoneham), 2016-05, Vol.93 (5), p.392-397

2016

Volltextzugriff (PDF)

Synthesis and characterization of PbTe thin films by atomic layer deposition

Physica status solidi. A, Applications and materials science, 2014-06, Vol.211 (6), p.1329-1333

2014

Volltextzugriff (PDF)

Patterns of Care In The Workup And Management of Non-Metastatic And Metastatic Colorectal Cancer

Value in health, 2015-05, Vol.18 (3), p.A191-A191

2015

Volltextzugriff (PDF)

PDB11 Health Outcomes of Initiating Basal Analog Insulin via Disposable Pens Among Patients With Type-2 Diabetes in a National Managed Care Plan in the United States

Value in health, 2012-06, Vol.15 (4), p.A172-A172

2012

Volltextzugriff (PDF)

Health care cost savings associated with aripiprazole once-monthly (AOM) treatment among schizophrenia patients with psychiatric hospitalizations prior to AOM treatment initiation

Value in health, 2014-05, Vol.17 (3), p.A216-A216

2014

Volltextzugriff (PDF)

Cost and Resource Utilization Comparisons of Second Generation Antihistamines vs. Montelukast in Treatment of Allergic Rhinitis: Retrospective Analysis of a Large National Insurance Claims Database

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.S213-S213

2009

Volltextzugriff (PDF)

The association between adverse dental outcomes and intravenous versus oral bisphosophonates within cancer patients

Bone (New York, N.Y.), 2009-06, Vol.44, p.S279-S279

2009

Volltextzugriff (PDF)

Docetaxel in Combination with Doxorubicin and Cyclophosphamide as Adjuvant Treatment for Early Node-Positive Breast Cancer in the USA: A Cost-Effectiveness and Cost-Utility Analysis

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.2091-2091

2009

Volltextzugriff (PDF)

PCN10 - Patterns of Care In The Workup And Management of Non-Metastatic And Metastatic Colorectal Cancer

Value in health, 2015-05, Vol.18 (3), p.A191-A191

2015

Volltextzugriff (PDF)

PMH43 - Health care cost savings associated with aripiprazole once-monthly (AOM) treatment among schizophrenia patients with psychiatric hospitalizations prior to AOM treatment initiation

Value in health, 2014-05, Vol.17 (3), p.A216-A216

2014

Volltextzugriff (PDF)

Long-term survival benefits of docetaxel plus cyclophosphamide compared to doxorubicin plus cyclophosphamide in the adjuvant treatment of operable breast cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.563-563

2009

Volltextzugriff (PDF)

Treatment patterns of docetaxel and paclitaxel in patients with early-stage breast cancer in a community oncology center

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e17550-e17550

2009

Volltextzugriff (PDF)

PCN9 USING PROPENSITY SCORES TO REDUCE SELECTION BIAS IN AN OBSERVATIONAL STUDY COMPARING RASBURICASE TO ALLOPURINOL IN THE US

Value in health, 2010, Vol.13 (3), p.A24-A25

2010

Volltextzugriff (PDF)

PCN11 ASSESSING THE TREATMENT EFFECT OF RASBURICASE ALONE VERSUS RASBURICASE AND ALLOPURINOL COMBINATION THERAPY USING PROPENSITY SCORES

Value in health, 2010, Vol.13 (3), p.A25-A25

2010

Volltextzugriff (PDF)

Concordance to National Comprehensive Cancer Network (NCCN) clinical practice guidelines (GL) for imaging work-up of patients with metastatic breast cancer: An analysis from the commercial managed care claims PharMetrics (PM) and SEER/Medicare (SM) databases

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1104-1104

2010

Volltextzugriff (PDF)

PMH5 COMPARISON OF RISK OF UPPER GASTROINTESTINAL HEMORRHAGE AMONG SSRI-USERS WITHIN U.S. MANAGED CARE POPULATION

Value in health, 2008, Vol.11 (6), p.A580-A580

2008

Volltextzugriff (PDF)

Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in the United States

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.1037-1037

2009

Volltextzugriff (PDF)

PCN24 THE ECONOMIC IMPLICATIONS OF RASBURICASE TREATMENT IN ADULT TUMOR LYSIS SYNDROME PATIENTS

Value in health, 2009, Vol.12 (3), p.A40-A40

2009

Volltextzugriff (PDF)

PCN125 NUMBER OF DOCETAXEL TREATMENT CYCLES AND OVERALL SURVIVAL FOR METASTATIC PROSTATE CANCER–RESULTS FROM A US LOCAL COMMUNICTY PRACTICE

Value in health, 2010, Vol.13 (3), p.A47-A48

2010

Volltextzugriff (PDF)

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

Value in health, 2009, Vol.12 (3), p.A45-A45

2009

Volltextzugriff (PDF)

PCN66 COST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY AMONG U.S. BREAST CANCER PATIENTS

Value in health, 2009, Vol.12 (3), p.A48-A48

2009

Volltextzugriff (PDF)

PCN68 US AND CANADIAN COST-EFFECTIVENESS ANALYSES OF US ONCOLOGY TRIAL 9735 PROVIDE ADDITIONAL RATIONALE FOR AVOIDING ANTHRACYCLINES IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

Value in health, 2009, Vol.12 (7), p.A269-A269

2009

Volltextzugriff (PDF)

The economic implications of rasburicase treatment in adult tumor lysis syndrome patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e17503-e17503

2009

Volltextzugriff (PDF)

The economic implications of rasburicase treatment in pediatric tumor lysis syndrome patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.10050-10050

2009

Volltextzugriff (PDF)

Coil Migration to Pulmonary Vasculature: Complication of Coil Embolization

Chest, 2013, Vol.144 (4), p.134A-134B

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Are women benefiting from the Affordable Care Act? A real-world evaluation of the impact of the Affordable Care Act on out-of-pocket costs for contraceptives

Synthesis and characterization of PbTe thin films by atomic layer deposition

Patterns of Care In The Workup And Management of Non-Metastatic And Metastatic Colorectal Cancer

PDB11 Health Outcomes of Initiating Basal Analog Insulin via Disposable Pens Among Patients With Type-2 Diabetes in a National Managed Care Plan in the United States

Health care cost savings associated with aripiprazole once-monthly (AOM) treatment among schizophrenia patients with psychiatric hospitalizations prior to AOM treatment initiation

Cost and Resource Utilization Comparisons of Second Generation Antihistamines vs. Montelukast in Treatment of Allergic Rhinitis: Retrospective Analysis of a Large National Insurance Claims Database

The association between adverse dental outcomes and intravenous versus oral bisphosophonates within cancer patients

Docetaxel in Combination with Doxorubicin and Cyclophosphamide as Adjuvant Treatment for Early Node-Positive Breast Cancer in the USA: A Cost-Effectiveness and Cost-Utility Analysis

PCN10 - Patterns of Care In The Workup And Management of Non-Metastatic And Metastatic Colorectal Cancer

PMH43 - Health care cost savings associated with aripiprazole once-monthly (AOM) treatment among schizophrenia patients with psychiatric hospitalizations prior to AOM treatment initiation

Long-term survival benefits of docetaxel plus cyclophosphamide compared to doxorubicin plus cyclophosphamide in the adjuvant treatment of operable breast cancer

Treatment patterns of docetaxel and paclitaxel in patients with early-stage breast cancer in a community oncology center

PCN9 USING PROPENSITY SCORES TO REDUCE SELECTION BIAS IN AN OBSERVATIONAL STUDY COMPARING RASBURICASE TO ALLOPURINOL IN THE US

PCN11 ASSESSING THE TREATMENT EFFECT OF RASBURICASE ALONE VERSUS RASBURICASE AND ALLOPURINOL COMBINATION THERAPY USING PROPENSITY SCORES

Concordance to National Comprehensive Cancer Network (NCCN) clinical practice guidelines (GL) for imaging work-up of patients with metastatic breast cancer: An analysis from the commercial managed care claims PharMetrics (PM) and SEER/Medicare (SM) databases

PMH5 COMPARISON OF RISK OF UPPER GASTROINTESTINAL HEMORRHAGE AMONG SSRI-USERS WITHIN U.S. MANAGED CARE POPULATION

Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in the United States

PCN24 THE ECONOMIC IMPLICATIONS OF RASBURICASE TREATMENT IN ADULT TUMOR LYSIS SYNDROME PATIENTS

PCN125 NUMBER OF DOCETAXEL TREATMENT CYCLES AND OVERALL SURVIVAL FOR METASTATIC PROSTATE CANCER–RESULTS FROM A US LOCAL COMMUNICTY PRACTICE

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

PCN66 COST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY AMONG U.S. BREAST CANCER PATIENTS

PCN68 US AND CANADIAN COST-EFFECTIVENESS ANALYSES OF US ONCOLOGY TRIAL 9735 PROVIDE ADDITIONAL RATIONALE FOR AVOIDING ANTHRACYCLINES IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

The economic implications of rasburicase treatment in adult tumor lysis syndrome patients

The economic implications of rasburicase treatment in pediatric tumor lysis syndrome patients

Coil Migration to Pulmonary Vasculature: Complication of Coil Embolization

Suchergebnisse filtern